https://orcid.org/0000-0002-0770-4743
Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Hans-Peter Marti, Abel Alberto Pavía López & Pedro Schwartzmann. (2024) Safety and tolerability of β-blockers: importance of cardioselectivity. Current Medical Research and Opinion 40:sup1, pages 55-62.
Read now
Read now
Piotr Jędrusik, Grzegorz Placha & Zbigniew Gaciong. (2023) Efficacy and safety of bisoprolol 5 mg plus amlodipine 5 mg in patients with hypertension uncontrolled on monotherapy with 5 mg of amlodipine, a phase III multicenter, randomized, double-blind, placebo-controlled clinical trial – the AMCOR study. Current Medical Research and Opinion 39:7, pages 939-946.
Read now
Read now
Articles from other publishers (4)
Heba Abd El-Aziz & Abdallah M. Zeid. (2024) Derivatization-free conventional and synchronous spectrofluorimetric estimation of atenolol and amlodipine. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 305, pages 123532.
Crossref
Crossref
Priya Takkar, Bholey Singh, Balaram Pani & Rakesh Kumar. (2023)
Design, synthesis and
in silico
evaluation of newer 1,4-dihydropyridine based amlodipine bio-isosteres as promising antihypertensive agents
. RSC Advances 13:48, pages 34239-34248.
Crossref
Crossref
S. R. Gilyarevsky, M. V. Golshmid & N. G. Bendeliani. (2022) Therapeutic Options for the Single Pill Combination of Lisinopril, Amlodipine and Rosuvastatin: a Systematic Review. Rational Pharmacotherapy in Cardiology 18:4, pages 480-488.
Crossref
Crossref
Mariam Bapir, Paola Campagnolo, Ana Rodriguez-Mateos, Simon S. Skene & Christian Heiss. (2022) Assessing Variability in Vascular Response to Cocoa With Personal Devices: A Series of Double-Blind Randomized Crossover n-of-1 Trials. Frontiers in Nutrition 9.
Crossref
Crossref